A bacterial infection occurs when bacteria enter or colonise a host and reproduce or otherwise interact with tissues in a manner that causes disease or inflammation. Bacteria are living single-celled organisms with their own cellular structures and metabolic systems. Unlike viruses, bacteria are complete cells capable of independent growth under suitable conditions, although they may depend on particular environmental nutrients and conditions.
Many bacteria are harmless or beneficial members of the normal human microbiota, while pathogenic bacteria can invade tissues, produce toxins, trigger damaging inflammation or disrupt normal physiological functions. The term bacterial infection therefore refers specifically to disease or colonisation caused by bacteria rather than simply the presence of bacteria somewhere on or in the body.
Bacterial disease can arise through several mechanisms. Some bacteria invade tissues, multiplying within cells or extracellular spaces and provoking inflammatory responses. Others produce toxins that damage host cells or interfere with physiological processes. Some establish infections by attaching to epithelial surfaces and forming biofilms, which are structured communities surrounded by protective extracellular material. Bacteria can also exploit breaks in skin, impaired mucosal barriers or weakened immune defences. The clinical consequences therefore depend on the bacterial species, strain, site of infection, bacterial load, virulence factors and characteristics of the host.
Bacteria are classified using characteristics such as cell shape, staining behaviour, genetic relationships, oxygen requirements, metabolic properties and surface structures. The Gram stain is particularly important clinically because it broadly distinguishes Gram-positive from Gram-negative bacteria according to differences in their cell envelopes. Gram-negative bacteria possess an outer membrane containing lipopolysaccharide, while Gram-positive bacteria have a comparatively thick peptidoglycan-rich cell wall. Other clinically relevant distinctions include aerobic versus anaerobic metabolism, spore formation and intracellular versus extracellular lifestyles. These biological differences influence which antibiotics can enter the organism and which molecular targets are available.
Bacterial infections can occur in virtually any body system. Examples include urinary tract infections, bacterial pneumonia, cellulitis, streptococcal throat infection, bacterial meningitis and tuberculosis. Some infections remain localised, while others can enter the bloodstream and produce bacteraemia or sepsis. The same bacterial species can produce different diseases depending on where it enters the body and the host's condition. Staphylococcus aureus, for example, can harmlessly colonise skin or nasal passages in some people but can cause skin infections, pneumonia, bloodstream infections and other serious diseases when it reaches susceptible tissues.
Transmission varies substantially among bacteria. Some spread through respiratory droplets or particles, some through contaminated food and water, some through sexual contact, some through direct contact, and others through wounds, animals or arthropod vectors. Certain bacteria are part of normal human flora and cause disease only when they enter normally sterile sites or when host defences are compromised. The route of entry therefore matters as much as the identity of the organism. Prevention can involve vaccination where available, food and water hygiene, hand hygiene, wound care, safer sexual practices, environmental controls and appropriate infection-control procedures in healthcare settings.
The immune system can often eliminate bacterial infections through innate and adaptive immune responses. Neutrophils and other innate immune cells rapidly respond to bacterial invasion, while antibodies and specialised lymphocytes contribute to longer-term defence. Inflammation helps recruit immune cells but can itself cause tissue damage when excessive. Some bacteria evade immunity through capsules, intracellular survival, biofilm formation, antigenic variation or other mechanisms. The outcome therefore represents an interaction between bacterial virulence and host defence. Healthy people can sometimes clear bacterial infections without antibiotics, whereas others require prompt antimicrobial treatment because their immune system cannot safely control the organism.
Antibiotics are designed to exploit differences between bacterial and human biology. Their targets include bacterial cell-wall synthesis, protein synthesis, DNA replication, RNA synthesis and metabolic pathways. Because human cells do not possess many of these structures or processes in the same form, appropriately selected antibiotics can damage bacteria more than host cells. However, antibiotics are not universally necessary for every bacterial infection. Some mild bacterial illnesses resolve spontaneously, while others can progress rapidly or cause complications and therefore require treatment. Clinical decisions consider the likely organism, site and severity of infection, patient risk factors, resistance patterns and evidence that treatment will provide meaningful benefit.
Antibiotic resistance is a major limitation in treating bacterial infections. Bacteria can acquire genetic changes or resistance genes that allow them to survive exposure to antibiotics. Resistance can arise through mutation and natural selection or through transfer of genetic material between bacteria. Inappropriate antibiotic use creates selection pressure that favours resistant organisms, although resistance also develops through unavoidable evolutionary processes whenever antibiotics are used. Resistant infections can require alternative medicines, longer treatment, intravenous therapy or specialist management. Appropriate prescribing is therefore important both for the individual patient and for preserving antibiotic effectiveness at population level.
